UnitedHealth Group Incorporated (UNH) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare.
Total Cash From Operating Activities Chart for UnitedHealth Group Incorporated
UnitedHealth Group Incorporated (UNH) operating cash flow for FY2025 was USD 19.7B, a -18.6% change from FY2024. UnitedHealth Group Incorporated's operating cash flow grew from USD 41.1M in 1989 to USD 19.7B in 2025 (47824.6% over 36 years). Operating cash flow compound annual growth rate: 5-year CAGR of -2.3%, 10-year CAGR of 7.3%, 20-year CAGR of 7.9%.
Total Cash From Operating Activities (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $339.08B
- Implied Share Price
- $377.76
- Enterprise Value
- $376.62B
- Revenue (TTM)
- $450.53B
- EBITDA
- $26.68B
- Profit Margin
- 3.14%
- Trailing P/E
- 24.29
- Forward P/E
- 16.58
- Price/Book (MRQ)
- 3.40
- Price/Sales (TTM)
- 0.75
- EV/EBITDA
- 14.70
- EV/Revenue
- 0.84
- Dividend Yield
- 0.00%
- Book Value
- $103.87
- Free Cash Flow (FY2025)
- $16.07B
- Free Cash Flow Yield
- 4.74%
Snapshot as of 14th October 2026 — not point-in-time controlled, may lag the live market by a few days.